HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
(3-nitrobenzoyl)alanine
inhibits kynurenine hydroxylase; structure in first source
Also Known As:
(m-nitrobenzoyl)alanine; m-nitrobenzoylalanine
Networked:
1
relevant articles (
0
outcomes,
1
trials/studies)
Bio-Agent Context: Research Results
Amino Acids, Peptides, and Proteins: 1
Amino Acids: 30675
Alanine: 4133
(3-nitrobenzoyl)alanine: 1
Related Diseases
1.
Brain Ischemia (Cerebral Ischemia)
07/01/1999 - "
Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia.
"
2.
Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
07/01/1999 - "
Two kynurenine hydroxylase inhibitors, (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfona mide (Ro 61-8048), have been tested as neuroprotective agents on brain lesions induced by bilateral carotid occlusion in gerbils or by middle cerebral artery occlusion in rats.
"
Related Drugs and Biologics
1.
Kynurenine 3-Monooxygenase (Kynurenine 3 Monooxygenase)
2.
Benzenesulfonamides
3.
Neuroprotective Agents